did the fda stop semaglutide has strictly clarified that with the national supply of GLP-1 medications stabilizing, compounders can no longer produce "essentially copies" of FDA-approved drugs. Enforcement discretion periods for drugs like and Last week @fda sends out

In contrast, weight loss magnitude during the pre-landmark period was not significantly associated with post-landmark all-cause mortality ( P = 0.14), the composite cardiovascular endpoint ( P = 0.55), incident cerebrovascular disease ( P = 0.25), incident heart failure ( P = 0.89), or incident valvular or rheumatic heart disease ( P = 0.43) (Fig

As an injection (Intramuscular, IM, or Subcutaneous, SC), it is highly effective for patients who cannot properly absorb Vitamin B12 through the digestive system due to underlying conditions like pernicious anThere are no known significant interactions between injectable B12 and food, as the injection bypasses the entire digestive system

doi:10.3390/nu11122908 238

Semaglu-2 (8mg/3ml) Pfp Injection 1's is not recommended for use in children, during pregnancy, or while breastfeeding

Brian L

What benefit design have you seen that improves access without shifting the bill to patients